Connection

DAVID POPLACK to Azacitidine

This is a "connection" page, showing publications DAVID POPLACK has written about Azacitidine.
Connection Strength

0.280
  1. Cerebrospinal fluid pharmacokinetics and toxicology of intraventricular and intrathecal arabinosyl-5-azacytosine (fazarabine, NSC 281272) in the nonhuman primate. Invest New Drugs. 1993 May-Aug; 11(2-3):135-40.
    View in: PubMed
    Score: 0.107
  2. Phase I trial and pharmacokinetic evaluation of fazarabine in children. Cancer Res. 1989 Sep 15; 49(18):5213-6.
    View in: PubMed
    Score: 0.083
  3. Preclinical pharmacology of arabinosyl-5-azacytidine in nonhuman primates. Cancer Res. 1988 Aug 01; 48(15):4294-8.
    View in: PubMed
    Score: 0.077
  4. Phase II study of 5-azacytidine in sarcomas of bone. Am J Clin Oncol. 1982 Aug; 5(4):411-5.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.